CR? [Regulatives / Guidelines]

posted by jag009  – NJ, 2012-10-16 23:22 (5005 d 13:12 ago) – Posting: # 9426
Views: 4,585

Hi Helmut,

❝ Yep. Luv nonparametrics. What do you mean by “we had to show that Tlag was not significantly different …”? In the US? Surprise.


A long long time ago (2000s) in my previous life we were developing a generic of a DR product which is designed to be given in the evening to have morning effect. The drug has a specific Tlag which FDA required us to meet in addition to BE criteria.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
245 visitors (0 registered, 245 guests [including 20 identified bots]).
Forum time: 12:34 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5